Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan;12(1):105-113.
doi: 10.1177/1932296817710478. Epub 2017 Jun 1.

Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data

Giada Acciaroli  1 , Giovanni Sparacino  1 , Liisa Hakaste  2   3 , Andrea Facchinetti  1 , Giorgio Maria Di Nunzio  1 , Alessandro Palombit  1 , Tiinamaija Tuomi  2   3   4 , Rafael Gabriel  5 , Jaime Aranda  6 , Saturio Vega  7 , Claudio Cobelli  1
Affiliations

Diabetes and Prediabetes Classification Using Glycemic Variability Indices From Continuous Glucose Monitoring Data

Giada Acciaroli et al. J Diabetes Sci Technol. 2018 Jan.

Abstract

Background: Tens of glycemic variability (GV) indices are available in the literature to characterize the dynamic properties of glucose concentration profiles from continuous glucose monitoring (CGM) sensors. However, how to exploit the plethora of GV indices for classifying subjects is still controversial. For instance, the basic problem of using GV indices to automatically determine if the subject is healthy rather than affected by impaired glucose tolerance (IGT) or type 2 diabetes (T2D), is still unaddressed. Here, we analyzed the feasibility of using CGM-based GV indices to distinguish healthy from IGT&T2D and IGT from T2D subjects by means of a machine-learning approach.

Methods: The data set consists of 102 subjects belonging to three different classes: 34 healthy, 39 IGT, and 29 T2D subjects. Each subject was monitored for a few days by a CGM sensor that produced a glucose profile from which we extracted 25 GV indices. We used a two-step binary logistic regression model to classify subjects. The first step distinguishes healthy subjects from IGT&T2D, the second step classifies subjects into either IGT or T2D.

Results: Healthy subjects are distinguished from subjects with diabetes (IGT&T2D) with 91.4% accuracy. Subjects are further subdivided into IGT or T2D classes with 79.5% accuracy. Globally, the classification into the three classes shows 86.6% accuracy.

Conclusions: Even with a basic classification strategy, CGM-based GV indices show good accuracy in classifying healthy and subjects with diabetes. The classification into IGT or T2D seems, not surprisingly, more critical, but results encourage further investigation of the present research.

Keywords: classification; continuous glucose monitoring; glycemic variability; impaired glucose tolerance; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Representative CGM traces from representative healthy (first panel), IGT (second panel), and T2D (third panel) subjects.
Figure 2.
Figure 2.
Simplified representation of sigmoid function with n = 2 dimensions. The sigmoid surface divides the probabilistic space into two areas, corresponding to the two classes.
Figure 3.
Figure 3.
Scheme of confusion matrix for the evaluation of classification performance.
See this image and copyright information in PMC

References

    1. Nalysnyk L, Hernandez-Medina M, Krishnarajah G. Glycaemic variability and complications in patients with diabetes mellitus: evidence from a systematic review of the literature. Diabetes Obes Metab. 2010;12(4):288-298. - PubMed
    1. Hirsch IB. Glycemic variability and diabetes complications: does it matter? Of course it does!. Diabetes Care. 2015;38(8):1610-1614. - PubMed
    1. Rizzo MR, Barbieri M, Marfella R, Paolisso G. Reduction of oxidative stress and inflammation by blunting daily acute glucose fluctuations in patients with type 2 diabetes. Diabetes Care. 2012;35(10):2076-2082. - PMC - PubMed
    1. Timmons JG, Cunningham SG, Sainsbury CA, Jones GC. Inpatient glycemic variability and long-term mortality in hospitalized patients with type 2 diabetes. J Diabetes Complications. 2016;31(2):479-482. - PubMed
    1. Kilpatrick ES, Rigby AS, Atkin SL. For debate. Glucose variability and diabetes complication risk: we need to know the answer. Diabet Med. 2010;27(8):868-871. - PubMed

Publication types

MeSH terms